High frequency of cytolytic T lymphocytes directed against a tumor-specific mutated antigen detectable with HLA tetramers in the blood of a lung carcinoma patient with long survival

Cancer Research

Volumn 61, Issue 9, 2001, Pages 3718-3724

  Karanikas, V ^a   Colau, D ^a   Baurain, J F ^a   Chiari, R ^a   Thonnard, J ^a   Gutierrez Roelens, I ^a   Goffinet, C ^a   Van Schaftingen, E ^a   Weynants, P ^a   Boon, T ^a   Coulie, P G ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; HLA A2 ANTIGEN; HLA ANTIGEN; MALATE DEHYDROGENASE (DECARBOXYLATING); T LYMPHOCYTE RECEPTOR; TETRAMER; TUMOR ANTIGEN;

ANTIGEN DETECTION; ANTIGEN SPECIFICITY; ARTICLE; BLOOD SAMPLING; CHROMOSOME 6; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENE FREQUENCY; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; HETEROZYGOSITY LOSS; HLA SYSTEM; HUMAN; HUMAN CELL; LUNG CARCINOMA; PRIORITY JOURNAL; SURVIVAL TIME;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CHROMOSOMES, HUMAN, PAIR 6; DNA, COMPLEMENTARY; DNA, NEOPLASM; EPITOPES; HLA-A2 ANTIGEN; HUMANS; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; MALATE DEHYDROGENASE; MALE; MICE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POINT MUTATION; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION;

EID: 0035328852     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. T cell-defined tumor antigens
2. Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1
3. Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3
4. Vaccination with MAGE-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma
5. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells
6. Antitumor immunity at work in a melanoma patient
7. High frequency of autologous antimelanoma CTLs directed against an antigen generated by a point mutation in a new helicase gene
8. Derivation of tumor-specific cytolytic T cell clones from two lung cancer patients with long survival
9. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes
10. Guanidine isothiocyanate preparation of total RNA
11. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill
12. Peptide synthesis. Part 2. Procedures for solid phase synthesis using Nα-fluorenylmethysoxycarbamylamino-acid on polymide supports. Synthesis of substance P and of acyl carrier protein 65-74 decapeptide
13. An HLA class I peptide-binding assay based on competition for binding to class I molecules on intact human B cells. Identification of conserved HIV-1 polymerase peptides binding to HLA-A*0301
14. Phenotypic analysis of antigen-specific T lymphocytes
15. Cytotoxic T-lymphocyte response to autologous human squamous cell cancer of the lung: Epitope reconstitution with peptides extracted from HLAAw68
16. HER2/neu-derived peptides are shared antigens among human non-small cell lung cancer and ovarian cancer
17. The peptide recognized by HLA-A68.2-restricted, squamous cell carcinoma of the lung-specific cytotoxic T lymphocytes is derived from a mutated elongation factor 2 gene
18. Peptide recognition by two HLA-A2/Tax11-19-specific T cell clones in relationship to their MHC/peptide/TCR crystal structures
19. Generation of an immunodominant CTL epitope is affected by proteasome subunit composition and stability of the antigenic protein
20. IFN-γ exposes a cryptic cytotoxic T lymphocyte epitope in HIV-1 reverse transcriptase
21. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients
22. High frequencies of naive Melan-A/MART-1-specific CD8+ T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals
23. Tetramer-guided analysis of TCR β-chain usage reveals a large repertoire of melan-A-specific CD8+ T cells in melanoma patients
24. Individual differences in the orientation of the cytolytic T cell response against mouse tumor P815